Stockreport

BRIEF-Flex Pharma reports positive topline data from exploratory phase 2 trial of FLX-787 in ALS [Reuters]

FLEX PHARMA  (FLKS) 
Last flex pharma earnings: 8/1 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.flex-pharma.com/investor-overview
PDF BRIEF-Flex Pharma reports positive topline data from exploratory phase 2 trial of FLX-787 in ALS | Reuters Reuters Staff 1 Min Read Nov 6 (Reuters) - Flex Pharma Inc * F [Read more]